Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NMDA antagonists ameliorate ototoxicity of aminoglycoside antibiotics

Dec. 12, 1996

Janssen files for lower-dose risperidone in U.S.

Dec. 12, 1996

New antidepressant compounds in development at HMR

Dec. 12, 1996

Positive GABAA receptor complex modulators claimed

Dec. 12, 1996

DepoTech files IND for DepoMorphine

Dec. 11, 1996

New neurotensin receptor ligands from Sanofi

Dec. 11, 1996

Knoll claims potential anticonvulsants

Dec. 11, 1996

Paracetamol safety established in pregnant mothers and their babies

Dec. 10, 1996

FDA approves new agent for spasticity

Dec. 10, 1996

New neuroleptic agents reported by Ferrer

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...